2014-07-28T14:49:32-05:00 2013-09-30 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE INDIANAPOLIS IN 46204 990 2012-10-01 042263040 Dana-Farber Cancer Institute Inc % STEVEN CONNOLLY DANA 6176323000 450 Brookline Avenue BP418 Suite Boston MA 02215 KAREN BIRD 2014-07-24 3176817000 2012 2015-11-30 17:44:51Z Edward J Benz Jr MD 450 BROOKLINE AVE Boston MA 02215 1059403088 false X www.dana-farber.org X 1951 MA The mission of DFCI is to provide expert, compassionate care to children & adults with cancer while advancing the understanding, diagnosis, treatment, cure, & prevention of cancer & related diseases. 77 64 4859 5000 0 0 398632881 393393949 602927602 639632558 293433 224324 19417675 23590819 1021271591 1056841650 31789972 26833850 0 0 352299705 369880843 2909019 3391495 21339874 595078313 623617670 982077009 1023723858 39194582 33117792 1605048122 1790428005 568884792 608044913 1036163330 1182383092 THE MISSION OF DANA-FARBER CANCER INSTITUTE IS TO PROVIDE EXPERT, COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. AS AN AFFILIATE OF HARVARD MEDICAL SCHOOL AND A COMPREHENSIVE CANCER CENTER DESIGNATED BY THE NATIONAL CANCER INSTITUTE, THE INSTITUTE ALSO PROVIDES TRAINING FOR NEW GENERATIONS OF PHYSICIANS AND SCIENTISTS, DESIGNS PROGRAMS THAT PROMOTE PUBLIC HEALTH PARTICULARLY AMONG HIGH-RISK AND UNDERSERVED POPULATIONS, AND DISSEMINATES INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES TO OUR TARGET COMMUNITY ACROSS THE UNITED STATES AND THROUGHOUT THE WORLD. false false 539264992 779469 639632558 Provided specialized, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. 274052701 26054381 Research at DFCI is staking out new territory in the fight against cancer, from advancing the understanding of the genetic makeup of cancer cells to developing novel therapies to diagnose, treat, and prevent the disease. 22874872 Through DFCI's community benefits programs, DFCI works in collaboration with community organizations to promote greater public health. See the community benefits report general explanation included in Schedule H. 836192565 true true false true false false false true false true true false false true true false false true false false true true false true true false true true true false true true false false false false false true false true false true true true false false false true true true true false true 496 35 true 4859 true false true CJ false false false true true false false false false X 77 64 true false true false false false false true true false false true true true true true true true true false AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X STEVEN CONNOLLY 6176323000 C/O DFCI 450 BROOKLINE AVE BP418 Boston MA 02215 X Bekenstein Joshua 2.0 X X 0 0 0 Benz Edward J JR MD 42.0 8.0 X X 1067826 130609 221767 Berkowitz Roger 1.0 X 0 0 0 Berylson Amy S 1.0 X 0 0 0 Brown Hon Frederick 1.0 X 0 0 0 Champa Michael A 1.0 X 0 0 0 Cohen Marc A 1.0 X 0 0 0 Countryman Gary L 2.0 X X 0 0 0 Cox Howard 1.0 X 0 0 0 Curtin Neal J ESQ 2.0 X X 0 0 0 Dana Charles A III 1.0 X 0 0 0 Darehshori Nader F 1.0 X 0 0 0 Farrington Thomas A 1.0 X 0 0 0 Fine James L 1.0 X 0 0 0 First Robert C 1.0 X 0 0 0 Gelb Arthur ScD 1.0 X 0 0 0 Gibson Nancy Q 1.0 X 0 0 0 Gosman Abraham D 1.0 X 0 0 0 Hadley Christopher 1.0 X 0 0 0 Harkins David V 1.0 X 0 0 0 Grubman Richard 1.0 X 0 0 0 Heller Frances 1.0 X 0 0 0 Jamieson Jane P 1.0 X 0 0 0 Kafker Hon Scott 1.0 X 0 0 0 Kelley Joseph 1.0 X 0 0 0 Knez Brian J 2.0 X X 0 0 0 Koppel Steven P 1.0 X 0 0 0 Kopperl Paul B 1.0 X 0 0 0 Koster Stephen P ESQ 1.0 X 0 0 0 Kraft Robert K 1.0 X 0 0 0 Krakoff Sandra G 1.0 X 0 0 0 Lockwood Roger A 1.0 X 0 0 0 Lubin Richard K 1.0 X X 0 0 0 Lucas Bradley A 1.0 X 0 0 0 Marshall John L III 1.0 X 0 0 0 McNay Joseph C 1.0 X 0 0 0 Meagher William F 1.0 X 0 0 0 Morse Richard P 2.0 X X 0 0 0 Nathan David G MD 50.0 X 230005 0 29056 Norberg Joseph E 1.0 X 0 0 0 O'Connor John J 1.0 X 0 0 0 O'Reilly Vincent M 2.0 X X 0 0 0 Owens Edward O 1.0 X 0 0 0 Palandjian Peter 1.0 X 0 0 0 Pasquarello Theodore 1.0 X 0 0 0 Pearlstein Jean F 1.0 X 0 0 0 Perini David B 1.0 X 0 0 0 Perini Eileen 1.0 X 0 0 0 Perlmutter Steven P ESQ 1.0 X 0 0 0 Poduska Susan M 1.0 X 0 0 0 Pohl Elizabeth 1.0 X 0 0 0 Reynolds Robert 1.0 X 0 0 0 Rosenberg Ann M 1.0 X 0 0 0 Rosenthal Harvey 1.0 X 0 0 0 Rover Edward F 1.0 X 0 0 0 Sachs Robert J ESQ 1.0 X 0 0 0 Salmon Marjorie B 1.0 X 0 0 0 Salter Malcolm S 1.0 X 0 0 0 Sanders Rebecca 1.0 X 0 0 0 Sen Laura 1.0 X 0 0 0 Smith Richard A 2.0 X X 0 0 0 Smith Susan F 1.0 X 0 0 0 Socol Jerry M 1.0 X 0 0 0 Spivak Gloria H 1.0 X 0 0 0 Tempel Jean C 1.0 X 0 0 0 Terrana Beth F 1.0 X 0 0 0 Williams Frederica M 1.0 X 0 0 0 Yost George J III 1.0 X 0 0 0 DaSilva Kevin 1.0 X 0 0 0 Dobson Sean 1.0 X 0 0 0 Fine Stephen 1.0 X 0 0 0 Foulkes Helena 1.0 X 0 0 0 Linde Packman Karen 1.0 X 0 0 0 Perini Jennifer 1.0 X 0 0 0 Stansky Robert 1.0 X 0 0 0 Sullivan Ronald 1.0 X 0 0 0 Ting David 1.0 X 0 0 0 Boskey Richard S ESQ 50.0 X 515531 0 50426 Puhy Dorothy 50.0 X 706208 0 36324 Bird Karen 50.0 X 400002 0 50664 Bartel Sylvia 50.0 X 222534 0 41587 Griffin James D MD 50.0 X 1075226 0 44462 Papola Maria 50.0 X 302606 0 35568 Paresky Susan 50.0 X 579282 0 44281 Rollins Barrett J MD PHD 50.0 X 595597 0 39091 Sallan Stephen E MD 50.0 X 491643 0 39091 Bunnell Craig 50.0 X 409613 0 35406 Gettleman Wendy 50.0 X 174076 0 30075 Constantine Michael MD 50.0 X 860538 0 39857 Kaddis Mona MD 50.0 X 713889 0 28042 Nadler Lee MD 50.0 X 630105 0 45475 Kantoff Philip 50.0 X 575568 0 48685 Winer Eric 50.0 X 598216 0 48453 Porter Janet X 213689 0 20139 Herring Thomas X 145457 0 15366 Reid Ponte Patricia X 387521 0 43049 Shulman Lawrence N MD X 637256 0 44965 11532388 130609 1031829 764 true true false Walsh Brothers Inc 210 Commercial Street BOSTON MA 02109 Construction Service 17075026 Partners Healthcare System Inc PO Box 3715 BOSTON MA 02241 Information Systems 67968641 Brigham and Women's Physicians Org 111 Cypress Street BROOKLINE MA 02445 Medical Services 11881413 Harvard University 1350 Massachusetts Ave CAMBRIDGE MA 02138 Research Services 9825874 The Brigham and Women's Hospital 75 Francis Street BOSTON MA 02115 Medical Services 41002527 378 466445 20953898 132889339 239084267 4723642 393393949 NET PATIENT SERVICE REVENUE 621110 639632558 639632558 639632558 224324 224324 0 7810144 7810144 4251515 4251515 0 4251515 4251515 0 687147 2561438 -1874291 -1874291 0 0 PARKING LOT REVENUE 812930 5280282 5280282 FOOD SERVICE REVENUE 722210 3019416 3019416 WCP BOUTIQUE INCOME 446199 1091215 1091215 4012538 4012538 13403451 1056841650 639632558 23815143 25632969 25632969 0 1200881 1200881 0 7578434 3133799 3712997 731638 311047 311047 294924327 229514121 53481340 11928866 18496429 14253622 3477053 765754 27037159 20835234 5082583 1119342 21533447 16593993 4047966 891488 6787314 1863346 4923968 3677025 3030690 627353 18982 442188 442188 221087 221087 3391495 3391495 0 110347971 96922474 13293853 131644 3862663 2161671 837496 863496 28743210 18908854 9212039 622317 42498847 14209736 28266667 22444 0 65585182 51198373 14380568 6241 8707128 3052817 5584975 69336 0 2762554 1078003 1211017 473534 12761393 12761393 0 63872667 52096243 11776424 4150111 2604111 1546000 OTHER PATIENT CARE EXPENSES 18616195 18616195 BAD DEBT EXPENSE 4175237 4175237 MISCELLANEOUS 19288004 14697775 4286932 303297 MEDICAL SUPPLIES EXPENSE 227118894 227118894 1023723858 836192565 166191419 21339874 0 0 32808941 61796976 88438087 72699473 103184171 99585081 857578 1136762 0 0 0 0 13298299 13218325 17054853 17195831 1183273210 537196522 644774769 646076688 0 0 0 0 0 0 5844580 7894580 698786844 870824289 1605048122 1790428005 79688597 87118430 0 0 0 0 283448745 279981307 0 0 0 0 35277888 84516167 0 0 170469562 156429009 568884792 608044913 X 477225008 556219441 406939276 467303055 151999046 158860596 1036163330 1182383092 1605048122 1790428005 X 33117792 113101970 X false true X true true true X 341933668 308112408 440670897 398632881 393393949 1882743803 0 0 341933668 308112408 440670897 398632881 393393949 1882743803 0 1882743803 9778144 12834800 12603828 10185220 12285983 57687975 1147 1147 7980777 7853536 10965879 11866982 11529160 50196334 1990629259 2719976485 0.94580 0.94370 X Other Income Includes Cafeteria Income, Parking Lot Income, Special Event Gross Income, Management Income, and Other Miscellanous Income. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true false true false true 221087 true 13204 false false 234291 false Schedule C Part II-B Supplemental Lobbying Information O'NEILL, ATHY & CASEY, P.C. - provided federal legislative and government relations consulting services to the Conference of Boston Teaching Hospitals, of which we are a member. VAN SCOYOC - provided federal legislative consulting to DFCI. MCDERMOTT, QUILTY & MILLER, LLP - provided state legislative and government relations consulting on health interests to DFCI. CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. On occasion, DFCI executive leadership meet with state and federal elected officials to advocate for the passage of legislation and funding to advance cancer research and treatment, and legislation to support services for cancer patients and cancer survivors. 1541734 X false 207975000 9214000 27582000 13652000 231119000 187242000 9879000 22169000 11315000 207975000 179577000 9098000 8614000 10047000 187242000 158022000 7951000 18605000 5001000 179577000 200409000 4304000 -9423000 27334000 9934000 158022000 0.69000 0.31000 false true true 7640445 7640445 735158241 272821741 462336500 139005808 68683776 70322032 269039431 195691005 73348426 32429285 32429285 646076688 INTEREST IN DANA-FARBER, INC. 770162737 MISCELLANEOUS ASSETS 100661552 870824289 0 AMOUNTS DUE TO 3RD PARTY PAYOR 66564147 RESEARCH ADVANCES 34676000 PROV FOR MED MALPRACTICE CLAIM 1479000 SWAP VALUATION LIABILITY 31563000 MISCELLANEOUS LIABILITIES 22146862 156429009 SCHEDULE D PART III, QUESTION 4 DESCRIPTION OF ORGANIZATION'S COLLECTIONS DFCI's collection of art is an array of art primarily received through donations and occasionally purchased. The collection can be found throughout the organization in patient and business areas. Patients and staff confirm the Institute's belief that artwork which is pleasing and appropriate for a health care setting greatly enhances the healing environment and makes a significant difference in the patient care experience. Schedule D, Part V, Question 4 Dana-Farber, Inc. (DFI) a related organization of Dana-Farber Cancer Institute, Inc. (DFCI) holds the endowments for DFCI and therefore reports the endowment funds on DFI's 990 accordingly. As described in detail in the Consolidated Audited Financial Statements, the Institute's endowments consist of numerous individual funds established for a variety of purposes. These endowments consist solely of donor-restricted endowment funds. As required by Generally Accepted Accounting Principles, net assets associated with endowment funds are classified and reported based on the existence or absence of donor-imposed restrictions. All uses of the organization's endowment funds are directly related to the Institute's exempt mission and purposes. true South Asia Program Services Subcontracted Research 353149 North America Program Services Subcontracted Research 60495 Europe (Including Iceland and Greenland) Program Services Subcontracted Research 634196 East Asia and the Pacific Program Services Subcontracted Research 153041 Central America and the Caribbean Program Services Jointly owned for ins 2562154 3763035 3763035 false false true false false false Schedule F, Part I, Line 2 Dana-Farber Cancer Institute, Inc.(DFCI)is responsible for the programmatic, administrative and financial monitoring of all awards made to sub-recipients under federal and non-federal sponsored projects. DFCI has the obligation, throughout the life of the award, to monitor the activities of sub-recipients to make certain that project objectives are completed and all funds are used for authorized purposes in compliance with applicable laws, regulations, and provisions of the prime contracts or grant agreements. Office of Research Accounting will monitor sub-recipients through OMB Circular A-133 reports. On a semi-annual basis, we will request certification of the OMB A-133 audit report from each sub-recipient. Circular A-133 requires that annual audits be completed within nine months of the end of the sub-recipients audit period. To this end certification letters must be prepared and distributed to every sub-recipient working on any externally sponsored award. The certification letters must be prepared and distributed annually, by June 30 of each year, requesting information about the sub-recipients' most recent completed fiscal year. The certification letters require the sub-recipient organization to state that the information they are providing fairly presents the standing of the organization in all material aspects and that they state one of the following [see Attachment A, page 1]: -They are subject to the requirements of A-133, the audit has been completed and there were no material conditions of non-compliance with federal regulations. -They are subject to the requirements of A-133, the audit has been completed, exceptions were noted and a copy of the audit report is provided. -They are subject to the requirements of A-133 but the audit has not been completed. -They are not subject to the requirements of A-133 because the organization did not receive $500,000 or more in federal awards during the fiscal year, is a for-profit corporation, or is a non-U.S. based entity. Follow up requests will be made to ensure that sub-recipients send reports: -Should no response to the certification letter be received within 60 days, a second certification letter will be sent. Should no response to the second letter be received within 30 days, the sub-recipient will be contacted by telephone. -If reports are not received, the Federal Audit Clearinghouse (FAC)Internet data dissemination system will be used to retrieve audit report information from the FAC database. This information will be reviewed to determine if an organization has any reportable conditions and/or audit findings required to be reported under OMB Circular A-33, subpart E, section .510(a). -Should attempts continue to be unsuccessful,the Director of Research Administration, in conjunction with Director of the Research Accounting will consider sanctions against the sub-recipient, including termination of the subcontract. Research Accounting will review all available information for compliance issues pertaining to funds from A-133 reports. The Director of Research Accounting will be notified of any compliance issues that pertain to funds passed through the Institute and will request corrective action plans from the management of the organization to determine if proper action has been implemented. Management will determine corrective action on deficiencies identified in audits and sub-recipient monitoring. The monitoring of sub-recipients, not subject to Circular A-133, will be based upon the judgment of management and will include such factors as the size of the award, percentage of the total program's funds awarded to the sub-recipient, budget adherence, any issues identified in the pre-award review, and other matters as deemed necessary. The complete Sub-Recipient Policy is available upon request. X X X X X true STRATEGIC FUNDRAISING telefundrai consulting false 128658 90315 38343 TRUESENSE MARKETING Direct Mail Consultant false 10081678 3173385 6908293 Dave Mcgillivray Sports Enterprise Event Logis false 127795 10210336 3391495 6946636 All States BMJF WALK 8150000 8022650 127350 0 0 111994 10171 7400 682901 MARATHON CHLNG 4753874 4503199 250675 0 0 35662 4519 0 281041 7 8737171 8428049 309122 0 0 31303 20347 0 1376100 21641045 20953898 687147 0 0 178959 35037 7400 2340042 2561438 -1874291 true true X true X 400. false true true false true true 13911895 4856014 9055881 0.00890 32064210 34412862 -2348652 7280480 7280480 0.00710 53256585 39268876 13987709 0.01600 2566529 2566529 0.00250 4660912 527045 4133867 0.00410 217964872 2912917 215051955 0.21090 363809 363809 0.00040 225556122 3439962 222116160 0.21790 278812707 42708838 236103869 0.23390 619294 619294 0.00060 394000 394000 0.00040 1013294 1013294 0.00100 true 2710117 27101 136110600 147638354 -11527754 X true true 1 1 DANA-FARBER CANCER INSTITUTE INC

450 BROOKLINE AVE BOSTON MA 02215

www.dana-farber.org X X X D-F/BWH @ FAULKNER D-F/BWH @ MILFORD D-F/BWH@ SOUTH SHORE DANA-FARBER CANCER INSTITUTE INC true X X X X X X X X X 13 true false true X X X X X X X X X X true false true true 400. false true X X X X X X true true X X X X X X true false X X X true X false false 1 DANA-FARBERNHOH

ELLIOTT MED CENTER 40 BUTTRICK RD LONDONDERRY NH 03053

MED ONCOLOGY & INFUSION UNIT Part I Part I, Line 3c In addition to providing a forty-five percent (45%) discount to all uninsured patients, pursuant to its written policy Dana-Farber Cancer Institute (DFCI) "may offer a patient an additional discount on an unpaid bill as authorized by the hospital/s Chief Financial Officer or his/her designee. Any such review shall be determined on a case by case basis, and which takes into consideration the patient's documented financial situation and the patient's inability to make a payment." Part I, Line 6a The community benefit report was completed by DFCI and is annually provided to the Massachusetts Attorney General's office, where it is then made public on their website. Part I, Line 7 DFCI's internal cost accounting system, which accounts for all Institute activity, was used to create the cost to charge ratio that was applied to charity care charges to determine the financial assistance cost (Line 7a). Line 7c reflects the specific cost incurred for the Institute's required funding of the State's Health Safety Net fund. Line 7f reflects the costs of education, as calculated on the Medicare cost report, less any applicable reimbursement received for it. Total bad debt expense to provide adequate provision for allowance for doubtful accounts of $4,175,237 was included in total functional expense on Form 990, Part IX, Line 25 Part II Part II, Line 1 Physical Improvements and housing-DFCI provides a limited number of low cost rooms that serve as a home away from home for oncology patients and their families while they are receiving treatment. Part II, Line 8 Diversity and Workforce Development: In collaboration with nearby health care institutions, DFCI offers English as a Second Language (ESL) classes to staff. Business Writing for Professionals is an onsite 6-month college prep course designed to help front-line employees enhance reading and writing skills necessary for success in the workplace and in the classroom. DFCI also continued its collaboration with The Partnership to train and to increase the number of people of color in leadership roles in the Boston community. DFCI has continued its collaboration with the YMCA Achievers Program to recognize employees of color for their accomplishments and demonstrated excellence in their profession. Part III Part III, Section A, Line 3 The amount of Bad Debt attributed to financial assistance patients is based on actual writeoffs. The Bad Debt amount should be treated as a community benefit as it is similar to Unreimbursed Financial Assistance, as reported and allowed (Part I Line 7a), but for a different population. Part III, Line 4 There is no footnote in the Audited Financial Statements that describes Bad Debt. The amount of Bad Debt expense on Line 2 $2,710,117 is from our general ledger and is based on the treatment of Bad Debt activity consistent with Generally Accepted Accounting Principles (GAAP). Part III, Line 8 The Medicare allowable costs of $147,638,354 come directly from the Medicare cost report and are based on Medicare's cost finding principles and methodologies. We strongly believe that the entire amount of the shortfall $11,527,754 should be treated as a community benefit, as this represents the Institute's commitment to the elderly and disabled community by providing services that are not reimbursed. Part III, Line 9b Within DFCI's credit and collections policy there are provisions that describe collection practices to be followed for patients who are known to qualify for charity care or financial assistance in accordance with federal and Massachusetts law. Part V Part V, Section A DFCI main campus is at 450 Brookline Ave., Boston, MA. Its following satellite locations (below) each operate under the same hospital license. Dana-Farber/Brigham and Women's Cancer Center at Faulkner Hospital 1153 Centre Street, Boston, MA 02130 Dana-Farber/Brigham and Women's Cancer Center at Milford Hospital 20 Prospect Street, Milford, MA 01757 Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital 101 Columbian Street, South Weymouth, MA 02190 Part V, Section B, Line 3 The DFCI's Community Benefits Office partnered with Health Resources in Action (HRiA), a non-profit public health consultancy organization in Boston, to undertake a two phase comprehensive community health assessment. In Phase I, social, economic, and epidemiological data at the community level were reviewed and analyzed to provide a health portrait of DFCI's priority communities (Roxbury, Mission Hill, Dorchester, Mattapan, and Jamaica Plain). Phase II involved a comprehensive qualitative study, where DFCI staff, community leaders, and residents provided feedback in focus groups and interviews to identify community needs and assets as well as areas for further community engagement and program expansion. Focus groups included staff members from the following community organizations: Roxbury Tenants, Boston Public Health Commission, Roxbury Comprehensive Health Center, Boston Asian: Yes, Tobin Community Center, Mission Hill Neighborhood Housing Services. In addition, community residents participated in focus groups hosted by Whittier Street Health Center and La Alianza Hispana. A total of 86 individuals participated in the Phase II qualitative research in order to gauge their perceptions of their neighborhood, their health concerns, what programming or services are most needed to address these concerns, and the role of DFCI in these efforts. Please see attached Community Health Needs Assessment Implementation Plan 2012-2015. Part V, Section B, Line 5a DFCI's implementation strategy is available on the DFCI website. http://www.dana-farber.org/About-Us/Community-Outreach/Cmmunity-Health-Nee ds-Assessment-Reporting.aspx http://www.dana-farber.org/uploadedFiles/Library/about-us/community-outrea ch/chna-implementation-plan.pdf Part V, Section B, Line 11 Pursuant to its written policy, in addition to providing a forty-five percent (45%) discount to all uninsured patients, DFCI "may offer a patient an additional discount on an unpaid bill as authorized by the hospital/s Chief Financial Officer or his/her designee. Any such review shall be determined on a case by case basis, and which takes into consideration the patient's documented financial situation and the patient's inability to make a payment." Part V, Section B, Line 14 b Billing invoices include Free Care Guidelines and contact information for financial assistance. Part V, Section B, Line 14 g The Insurance and Financial Assistance section of the DFCI website directs patient to financial counselors for guidance. Part V, Section B, Line 19 Due to the fact DFCI is a Cancer Institute it rarely provides emergency services. However, DFCI will provide emergent and urgent care without regard to the patient's identification, insurance coverage or ability to pay for services in accordance with the requirements of DFCI policy. In all of its patient care activities, DFCI shall remain in compliance with federal regulations such as title 42 Chapter 7 USC 1395 (DD) and the balanced budget act of 1998 (Public Law No 105.33). Part V, Line 20d In no event is a patient who has been determined to be eligible for financial assistance from DFCI charged more than the maximum amounts billed to other insured patients for emergency or medically necessary care, as determined in accordance with the "look-back" method descried in "Internal Revenue Service, Proposed Treasury Regulation Section 1.501(r), Additional Requirements for Charitable Hospitals; Proposed Rule (June 26, 2012). care, as determined in accordance with the "look-back" method descried in "Internal Revenue Service, Proposed Treasury Regulation Section 1.501(r), Additional Requirements for Charitable Hospitals; Proposed Rule (June 26, 2012). Part VI Part VI, Line 2 - Needs Assessment DFCI evaluates the appropriateness and effectiveness of prevention programs and has continued to focus on the incorporation of evidence-based approaches. The following resources are used to gather information. Community Benefits staff work to disseminate findings derived from DFCI's Center for Community Based Research (CCBR) projects to strengthen the design, implementation and evaluation of our cancer control programs. Dana-Farber staff continues to serve on various statewide and regional committees including the Massachusetts Comprehensive Cancer Control Coalition, and Boston Public Health Commission's Health Equity Committee. DFCI staff participates in local coalitions that seek to improve the health status of neighborhood residents. In partnership with these Coalitions, DFCI will continue to develop cancer prevention programs to meet the unique needs of these communities. DFCI has established a number of committees to assist in program evaluation including the Board of Trustees Community Programs Committee, the External Advisory Committee and the DFCI Internal Community Benefits Committee. Part VI, Line 3 - Patient Education of Eligibility for Assistance DFCI recognizes that some patients will not be able to pay for services rendered and may not be aware of the availability of available assistance. The Institute will also notify the patient about available DFCI financial assistance and payment plans that may be available to them. For those patients who are uninsured or underinsured, the Institute may assist patients in applying for coverage of services within a financial assistance program to cover some or all of their unpaid hospital bills, such as Mass Health, Care plus, Connector Care, Qualified Health Plan (QHP), Children's Medical Security Plan, Healthy Start, Health Safety Net, as well as a Medical Hardship discount based on the patient's documented income and allowable medical expenses. The Institute will provide, upon request, specific information about the eligibility process to be a Low Income Patient under the Massachusetts Health Safety Net Program. The Institute posts a signs regarding the availability of financial assistance as outlined in credit and collection policy in each registration office. Posted signs are clearly visible and legible to patients visiting these areas. The posted signs are poster size 12' by 18', font size , in English and Spanish. The Institute provides patients with information about financial assistance with each bill it sends to patients and in phone conversations with patients regarding bills. Part VI, Line 4 - Community Information DFCI serves a broad geographic and demographic community. DFCI's main campus is located in the Longwood Medical Area of the City of Boston. DFCI works closely with clinical partners to operate convenient, community-based centers in Milford, Massachusetts, Weymouth, Massachusetts and Londonderry, New Hampshire. DFCI also helps to enhance the cancer care and services at local community hospitals and health centers such as St. Elizabeth's Medical Center in Brighton, Massachusetts and Lawrence & Memorial Cancer Center in Waterford, Connecticut. Approximately seventy percent of DFCI's patients reside in Massachusetts. A substantial portion of other patients reside in New Hampshire, Maine, Connecticut, Rhode Island and New York. Women constitute approximately sixty-three percent of DFCI's patients (approximately 35,000 per year); with men constituting thirty seven percent (approximately 20,000 per year). DFCI's patients include children and adults; although approximately sixty five percent of patients range between forty and sixty-nine years of age. DFCI's focuses its community outreach efforts on its priority Boston neighborhoods of Roxbury, Mission Hill, Dorchester, Mattapan and Jamaica Plain (which collectively comprise 38% of Boston's overall population). According to the 2005-2009 American Community Survey, in Mattapan and Roxbury/Mission Hill, 87.8% and 53.1% of residents respectively identified themselves as Black. Approximately one-quarter of residents in Roxbury/Mission Hill (22.5%) and Jamaica Plain (20.9%) identified themselves as Latino. Census data show that in Roxbury/Mission Hill, 40.5% of individuals live in poverty, as do 39.4% of individuals in Mattapan. Part VI, Line 5 - Promotion of Community Health Community outreach at DFCI focuses on increasing awareness about the importance of cancer prevention, outreach, screening, early detection and clinical trials education. Examples of prevention programs are: 1. DFCI's Mammography Van (DFMV) DFCI's Mammography Van was launched as a joint venture between the City of Boston and DFCI in April 2002. The Van continues to be the only mobile mammography program in the Commonwealth of Massachusetts. It provides digital screening mammograms and breast health education to women 40 years of age and older. In partnership with 19 community-based organizations and neighborhood health centers, the Van is on the road 3-4 days per week year-round, serving all of Greater Boston. Ultimately, it aims to decrease breast cancer morbidity and mortality among medically underserved women and increase survival rates for those diagnosed with breast cancer. The mammogram on the van is treated as a point of entry into the larger health care system. Women who lack a primary care provider are referred to one of our partner Boston neighborhood health centers, and those who lack health insurance are encouraged to apply to the Connector. Priority populations include women who are low-income, elderly, immigrant, non-English speaking, and those of ethnic/racial and other minority backgrounds. Priority neighborhoods in Boston include Roxbury, Mattapan, Jamaica Plain, Dorchester and the South End. The Van provides an effective way for women to continually monitor their breast health and to stay connected to the health care system at large. In FY13, the Van provided 2,849 mammograms. Since program inception, Dana- Farber's Mammography Van has provided more than 37,000 mammograms to more than 17,000 unique patients. The largest racial and ethnic groups seen on the Van are Black (32%) and Latino (31%). Over the past year, almost 56% of van patients spoke a first language other than English. Van patients speak 40 different languages, including Spanish; Cape Verdean Creole; Haitian Creole; Portuguese; and Vietnamese. One hundred six breast cancer diagnoses have been confirmed for patients originally screened on the Van since program inception. Sixty-seven and a half percent (67.5%) of patients screened on the Van were returnees from prior years; 41.4% of van patients returned for re-screening in a "timely" manner (12-18 months from last screen). Eleven percent (11%) of van patients served this year had their baseline (first-ever) mammograms on the van. Three hundred twenty-eight patients (11.5%) screened on the van in the past year received a recommendation for follow-up. Over the past year, the insurance status of van patients was: less than 1% uninsured; 63.5% publicly insured (Medicare, MassHealth, Health Safety Net, etc); and 36.4% privately insured. 2. Open Door to Health: A Peer Led Cancer Prevention and Early Detection Program (ODH): With only 26% of Boston adult residents eating the recommended number of fruit and vegetable servings per day and 57% engaging in regular physical activity, ODH focuses on addressing barriers to healthy living in the community's built environment. Specifically the program seeks to increase access to fresh vegetables and opportunities for physical activity. The number of peer leaders has remained at 3 for each of the 4 participating housing developments: Madison Park, Mission Park, Orchard Gardens and Ruggles Shawmut. The program is being implemented in partnership with Madison Park Development Corporation and Roxbury Tenants of Harvard. In 2013, 2 Community Gardens, one belonging to Orchard Gardens and the other to Madison Park Village, were fully utilized by tenants. Each community offered two cycles of physical activity events (Zumba and Yoga.) Additionally, a walking club was organized during the late Spring and Summer in each community. The Community Supportive Agriculture (CSA) program was a success with 30 people from the community participating regularly in the program. ODH has been integrated into the Resident Service Office at each housing development, providing the infrastructure necessary for Resident Service Coordinators and Peer Leaders to work together in implementing the program. Furthermore, ODH partnered with Whittier Street Health Center to connect Housing Development residents to nutrition and cancer prevention workshops. 3. Evidence-Based Training: We continue to provide Evidence-Based training to community and faith-based organizations. These trainings teach participants how to choose, customize, and localize an evidence-based program to meet communi . 10. Community Events and Health Fairs: Each year DFCI participates in numerous community events that serve as vehicles for educating communities about cancer prevention, screening, early detection, clinical trials and treatment information. The accomplishments in FY 13 include: Whittier Street Health Center Community Resource Room: In July 2013, we presented a comprehensive summer health education series that focused on Healthy Eating, HPV-Cervical Cancer and Breast Cancer. Approximately 80 participants attended the sessions, with a mixture of Whittier patients and community residents. Fenway High School Collaborations: In partnership with Fenway High School we conducted 2 presentations on topics of Nutrition/Physical Fitness and Tobacco and approximately 35- 45 students were educated. Additionally, DFCI hosted approximately 25 high visibility events reaching over 500 people. We also placed monthly cancer educational information in The Metro newspaper and published materials included information on DFCI-sponsored community events and topical articles on the importance of diet and exercise in cancer prevention. Periodic educational materials were also published in El Mundo and The Bay State Banner newspapers. 11. Cancer Care Equity Program The Cancer Care Equity Program (CCEP) was established in January 2012 to serve as a bridge between research and outreach efforts to address cancer disparities at DFCI. Creation of the program demonstrates the commitment of DFCI to local communities at high risk and with limited access to high-quality treatment. The role of the CCEP is to: Improve local outcomes via clinical access to the spectrum of preventive medicine, treatment, and trials at DFCI for the underserved, Unite disparities-related research across the Institute, Initiate and facilitate research in cancer disparities, and Support established outreach and educational programs. Through these efforts, the CCEP aims to broaden access to vulnerable patient populations and join our community partners in the quest for equitable care across the spectrum of cancer-related disease. There are six targeted objectives that the CCEP hopes to achieve with its Clinical Outreach Initiative: (1) Decrease wait times for diagnosis and treatment of cancer for vulnerable patient populations. A group of five Medical Oncology clinicians, a geneticist, a genetic counselor, and a highly experienced program nurse navigator currently provide consultations in collaboration with primary care physicians through the Dana-Farber Community Cancer Care Clinic located at WSHC in Roxbury, MA. The clinical team is dedicated to issues regarding disparities and delivering high-quality cancer care to vulnerable patient populations. The physicians attend a clinic at WSHC, perform consultations, and aid in diagnosis and work-up of suspected oncologic issues. Patients diagnosed with cancer are referred to DFCI for potential treatment and diagnostic procedures. Imaging is performed at DFCI and Brigham and Women's Hospital (BWH) as needed. Upon completing treatment, patients have the option to enter the survivorship program at WSHC. In addition to their primary care provider, patients have the option of being followed by one of the program's medical oncologists at WSHC, as well as the program's nurse navigator and patient navigator. Navigation services are provided to each patient to ensure seamless movement through various systems as well as coordination of care. 165 patients received new consults and over 78 patients had follow-up visits. These patients have a wide range of diagnoses and have been referred to disease centers and specialty clinics within the DFCI and BWH system. We have created an electronic database to track our patients in the most efficient manner. We have also converted our new patient survey into an electronic version. Both databases can be merged for proficient data collection and analysis. In direct response to a high volume of referrals for genetic evaluations, we have added a geneticist and a genetic counselor to our team. We have also hired a bilingual patient navigator. (2) Increase awareness and knowledge of cancer prevention and treatment within vulnerable communities. DFCI clinicians provide monthly question-and-answer sessions to the health care providers at WSHC, focusing on their particular specialty. In addition to these Q & A sessions, educational lectures are also provided to patients, staff, and the community at large. These lectures focus on prevention, treatment, survivorship, and clinical trials. (3) Foster trust with providers and patients from vulnerable communities. Whittier Street Health Center is a federally-funded community health center located in Roxbury, MA. The Center provides comprehensive health services including primary care, behavioral health care, substance abuse services, dental care and eye care to approximately 25,000 patients. It has a long-standing mission to deliver high quality care to vulnerable patient populations. 83% of WSHC patients live in public housing, and 45% are best served in a language other than English. Of the patients treated at WSHC, 92% live below 200% of the poverty level. DFCI has a long-standing relationship with WSHC, and has established survivorship clinics and cancer prevention-related outreach programs over the years. By directly involving and encouraging contact between oncologists and clinicians that serve the community, Dana-Farber Community Cancer Care is establishing trust and a level of comfort that encourages referrals and collaborations. In addition, having visible DFCI oncology providers in vulnerable communities conveys a commitment to treatment equity. (4) Create a research cohort of patients referred via the WSHC outreach program for observational and interventional studies. All patients evaluated as part of the CCEP have the option of enrolling in a research study to create a WSHC cohort. This allows for observational studies examining disease presentation and treatment responses, as well as qualitative and interventional studies. The formation of this unique research cohort is an important part of the clinical program and provides an opportunity to bring together investigators across DFCI with interests in disparities. Clinical trial investigators, community based researchers, and laboratory based researchers are encouraged to consult the CCEP for questions about this research cohort. As of December, 2013, 92 patients have enrolled, representing over 80% of those who have been informed of the study to date. A subset of these patients also enrolled in a separate DFCI study that examined patient/caregiver and provider preferences to improve symptom management and quality of life among cancer patients. (5) Increase enrollment in clinical trials. Education regarding the concept of clinical trials is provided to all patients seen at DFCI under the CCEP program. By increasing access to DFCI and improving relationships with the community and providers, the program hopes to remove some of the structural barriers to clinical trial enrollment for vulnerable patient populations. The program also allows for an evaluation of barriers to clinical trial entry, and is attempting to differentiate systems-level barriers from patient-level barriers. (6) Create a model for addressing the health disparities gap in cancer care. The final objective for the CCEP is to create a national model for addressing health disparities gaps in cancer care. One of the program's goals is to develop a support program to aid organizations who wish to institute similar programs. Overall, outcomes for patients will be followed closely to determine the effect on diagnosis time, treatment choices, complications of treatments, and clinical trial enrollment. If the program shows improvement in outcomes for patients, it would allow for expansion of the pilot project to other community health centers. 12. DFCI Health Equity Reporting The CCEP is responsible for producing quarterly health equity reports and monitoring under-represented patients for adult and pediatric inpatient/outpatient oncology services at DFCI, including clinical trial participation. The aims of the CCEP's health equity reporting initiative are to: 1) establish a method for consistent collection of demographic data on patients seen at DFCI; 2) produce quarterly Health Equity Reports for DFCI leadership, and establish and equity report dashboard for variables that allow for real time review; and 3) support pilot interventions to address treatment related equity issues at DFCI. To accomplish these aims, a database has been developed to link the established data systems at DFCI and allow for one consistent report that includes data on race/ethnicity, language, and educational level. The database is currently being validated and anticipated to become operational in early 2014. 13. CCEP/IECD Cancer Disparities Research Symposium In collaboration with the D true Friends of Dana-Farber 450 Brookline Ave BOSTON MA 02215 371613621 501(C)(3) 50000 CANCER RES & DEVELP BAPTIST MEMORIAL HEALTH CARE FOUNDATION 350 NORTH HUMPHREYS BOULEVARD MEMPHIS TN 38120 581544781 501(C)(3) 44800 CANCER RES & DEVELP BETH ISRAEL DEACONESS MEDICAL CENTER HARVARD MEDICAL SCHOOL DEPT OF PATH D627 200 LONGWOOD AVE BOSTON MA 02115 042103881 501(C)(3) 1337025 CANCER RES & DEVELP BLOOD CENTER OF WISCONSIN PO BOX 78961 MILWAUKEE WI 532780961 391372542 501(C)(3) 96926 CANCER RES & DEVELP BOSTON UNIVERSITY OFFICE OF THE COMPTROLLER 881 COMMONWEALTH AVENUE BOSTON MA 02215 042103547 501(C)(3) 83067 CANCER RES & DEVELP BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE 11301 WILSHIRE BOULEVARD BUILDING 114 ROOM 218 LOS ANGELES CA 90073 954183712 501(C)(3) 7044 CANCER RES & DEVELP BRIGHAM AND WOMEN'S FAULKNER HOSPITAL PO BOX 414240 BOSTON MA 022414240 042768256 501(C)(3) 24676 CANCER RES & DEVELP BRIGHAM AND WOMEN'S PHYSICIANS ORG PO BOX 3684 BOSTON MA 022413684 043466314 501(C)(3) 582178 CANCER RES & DEVELP BRUCE W HOLLIS LABATORY SERVICES 1732 CANYON OAKS DR MOUNT PLEASANT SC 29464 286508076 n/a 61770 CANCER RES & DEVELP CEDARS-SINAI MEDICAL CENTER C/O GRANTS CONTRACTS ADMIN 8700 BEVERLY BLVD-METRO 203 475 WE LOS ANGELES CA 90048 951644600 501(C)(3) 17500 CANCER RES & DEVELP CINCINNATI CHILDREN'S HOSPITAL MED CTR 3333 BURNET AVENUE PULMONARY BIOLOGY ML 7009 CINCINNATI OH 452293039 310833936 501(C)(3) 48276 CANCER RES & DEVELP CITY OF LAWRENCE COLLECTOR OF TAXES PO BOX 1376 LAWRENCE MA 01841 046001394 501(C)(3) 18600 CANCER RES & DEVELP CLEVELAND CLINIC ATTN TISSUE PROCUREMENT 9500 EUCLID AVENUE L25 CLEVELAND OH 441950001 912153073 501(C)(3) 49292 CANCER RES & DEVELP CLEVELAND CLINIC FOUNDATION CANCER RESEARCH PO BOX 931568 CLEVELAND OH 441933010 340714553 501(C)(3) 8781 CANCER RES & DEVELP COLUMBIA UNIVERSITY OFFICE OF THE CONTROLLER 1700 BROADWAY 10TH FLMC 7409 NEW YORK NY 10019 135598083 501(C)(3) 53967 CANCER RES & DEVELP DUKE UNIVERSITY GRANTS AND CONTRACTS DEPT OF MEDINI PO BOX 3230 BUMC DURHAM NC 27710 560532129 501(C)(3) 139576 CANCER RES & DEVELP EDUCATION DEVELOPMENT CENTER ACCOUNT RECEIVABLES DEPT 43 FOUNDRY AVE WALTHAM MA 02453 042241718 501(C)(3) 58530 CANCER RES & DEVELP EMORY UNIVERSITY SCHOOL OF MEDICINE SUITE 530 1784 NORTH DECATUR ROAD ATLANTA GA 30322 580566256 501(C)(3) 1213365 CANCER RES & DEVELP EMPHATIC COMMUNICATIONS 120 STATE AVE NE 304 OLYMPIA WA 98501 912181405 n/a 10000 CANCER RES & DEVELP FLORIDA STATE UNIVERSITY SPONSORED RESEARCH ACCOUNTING SERVI 874 TRADITIONS WAY PO BOX 3064166 TALAHASSEE FL 323064166 591961248 Gvt 42987 CANCER RES & DEVELP FORT WAYNE MEDICAL ONCOLOGY & HEMATOLOGY 11143 PARKVIEW PLAZA DRIVE SUITE 1 FORT WAYNE IN 46845 351400631 n/a 10000 CANCER RES & DEVELP FRED HUTCHINSON CANCER RESEARCH CENTER RESEARCH CENTER /BIOLOGICS 1100 FAIRVIEW AVE N B1-010 SEATTLE WA 981091024 237156071 501(C)(3) 180576 CANCER RES & DEVELP FRONTIER SCIENCE & TECHNOLOGY RESEARCH 1244 BOYLSTON STREET BROOKLINE MA 02467 161056814 501(C)(3) 411669 CANCER RES & DEVELP GAY BAILEY EXECUTIVES CONSULTING LLC 158 WEST NEWTON STREET BOSTON MA 02118 460836988 n/a 13000 CANCER RES & DEVELP GREATER LAWRENCE FAMILY HEALTH CENTER 34 HAVERHIL STREET LAWRENCE MA 01841 042708824 501(C)(3) 15000 CANCER RES & DEVELP GREATER LOWELL HEALTH ALLIANCE 295 VARNUM AVE LOWELL MA 01854 270408037 501(C)(3) 25000 CANCER RES & DEVELP GROUP HEALTH INC CENTER FOR HEALTH STUDIES 1730 MINOR AVENUE SUITE 1600 SEATTLE WA 98101 910511770 501(C)(3) 22987 CANCER RES & DEVELP HARVARD PILGRIM HEALTH CARE DEPT OF ONCOLOGY 2 FENWAY PLAZA BOSTON MA 02215 042452600 501(C)(3) 97779 CANCER RES & DEVELP HARVARD UNIVERSITY DEPARTMENT OF STATISTICS 702 SCIENCE CENTER 1 OXFORD ST SC CAMBRIDGE MA 02138 042103580 501(C)(3) 7626734 CANCER RES & DEVELP HARVARD VANGUARD MEDICAL ASSOCIATES ATTN JOHN ROBINSON 133 BROOKLINE AVENUE BOSTON MA 02115 043397450 501(C)(3) 105535 CANCER RES & DEVELP HEALTH FOUNDATION OF CENTRAL MASS 446 MAIN STREET FLOOR 20 WORCESTER MA 01608 042633274 501(C)(3) 15000 CANCER RES & DEVELP HEALTH RESEARCH INC DEPT OF CANCER GENETICS ELM CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 50795 CANCER RES & DEVELP HEALTH RESOURCES IN ACTION INC 95 BERKELEY STREET BOSTON MA 02116 042229839 501(C)(3) 15000 CANCER RES & DEVELP HOOSIER ONCOLOGY GROUP INC 351 WEST 10TH STREET SUITE 330 INDIANAPOLIS IN 46202 260303542 501(C)(3) 53436 CANCER RES & DEVELP HOWARD UNIVERSITY 2400 6TH STREET NW WASHINGTON DC 20059 530204707 501(C)(3) 20333 CANCER RES & DEVELP IMMUNE DISEASE INSTITUTE CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE BOSTON MA 02115 042158520 501(C)(3) 165276 CANCER RES & DEVELP JACKSON STATE UNIVERSITY OFFICE OF GRANTS CONTRACTS PO BOX 17250 JACKSON MI 392170517 646000507 501(C)(3) 28743 CANCER RES & DEVELP JOSEPH M SMITH COMMUNITY HEALTH CENTER 287 WESTERN AVENUE ALLSTON MA 02134 237221597 501(C)(3) 7500 CANCER RES & DEVELP JOSLIN DIABETES CENTER BEETHAM EYE INSTITUTE ONE JOSLIN PLACE BOSTON MA 02215 042203836 501(C)(3) 49342 CANCER RES & DEVELP KAISER FOUNDATION RESEARCH INSTITUTE 1800 HARRISON STREET 16TH FL OAKLAND CA 946123433 941340523 501(C)(3) 198793 CANCER RES & DEVELP LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY 10355 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 330328688 501(C)(3) 481503 CANCER RES & DEVELP LATHAM BIOPHARM GROUP INC 2 CLOCK TOWER PLACE SUITE 440 MAYNARD MA 01754 043382742 n/a 27383 CANCER RES & DEVELP LAWRENCE BERKLEY NATIONAL LABORATORY CFO/ SPONSORED PROJECT OFFICE MS46R0125 BERKELEY CA 94720 942951741 n/a 95425 CANCER RES & DEVELP MARGAUX BIOLOGICS INC 4365 EXECUTIVE DRIVE SUITE 300 C/O GOODWIN PROCTOR SAN DIEGO CA 92121 271945802 n/a 165974 CANCER RES & DEVELP MASSACHUSETTS GENERAL HOSPITAL RESEARCH FINANCE 550-1001 50 STANIFORD STREET BOSTON MA 021142517 042697983 501(C)(3) 2680051 CANCER RES & DEVELP MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVE BLDG 16-849 CAMBRIDGE MA 02139 042103594 501(C)(3) 834461 CANCER RES & DEVELP MAYO CLINIC ARIZONA RESEARCH FINANCE PO BOX 4008 ROCHESTER MN 559034008 860800150 501(C)(3) 328594 CANCER RES & DEVELP MAYO CLINIC ROCHESTER ROCHESTER RESEARCH ACCOUNTING 200 FIRST STREET SW ROCHESTER MN 55905 411937751 501(C)(3) 27060 CANCER RES & DEVELP MOUNT SINAI SCHOOL OF MEDICINE LEVY LIBRARY ONE GUSTAVE L LEVY PLACE BOX 1102 NEW YORK NY 100296574 136171197 501(C)(3) 76904 CANCER RES & DEVELP NEW ENGLAND RESEARCH INSTITUTE 9 GALEN STREET WATERTOWN MA 02472 042919509 n/a 63140 CANCER RES & DEVELP NEW YORK UNIVERSITY SCHOOL OF MEDICINE THE STEINHARDT SCHOOL OF EDUCATION 246 GREENE ST 6TH FLOOR NEW YORK NY 10003 135562309 501(C)(3) 65059 CANCER RES & DEVELP NORTHWESTERN UNIVERSITY 633 CLARK STREET R00M G-547 ACCOUNTING SERVICES RESEARCH EVANSTON IL 602081112 362167817 501(C)(3) 246938 CANCER RES & DEVELP POMONA VALLEY HOSPITAL MEDICAL CENTER ATTN GLENDA FERGUSON 1798 N GAREY AVENUE POMONA CA 91767 951115230 501(C)(3) 47971 CANCER RES & DEVELP PREVENT INC 2425 N CENTER STREET PMB 162 HICKORY NC 28601 561954986 n/a 27974 CANCER RES & DEVELP PROGERIA RESEARCH FOUNDATION PO BOX 3453 PEABODY MA 01961 043460220 501(C)(3) 35348 CANCER RES & DEVELP PROSTATE CANCER FOUNDATION ATTN JONATHAN SIMONS MD 1250 FOURTH ST SUITE 360 SANTA MONICA CA 90401 954418411 501(C)(3) 1800000 CANCER RES & DEVELP RAND CORPORATION FILE 53174 LOS ANGELES CA 900743174 951958142 501(C)(3) 148796 CANCER RES & DEVELP REGENTS OF THE UNIVERSITY OF MICHIGAN BOX 223131 PITTSBOURGH PA 152512131 386006309 501(C)(3) 15000 CANCER RES & DEVELP REGENTS OF UNIVERSITY OF CALIFORNIA ONE SHIELDS AVE 1200 DUTTON HALL DAVIS CA 95616 943067788 501(C)(3) 257970 CANCER RES & DEVELP REGENTS OF UNIVERSITY OF MINNESOTA OFFICE SPONSORED FINANCIAL REP 200 OAK STREET SE SUITE 450 MINNEAPOLIS MN 554552070 416007513 Gvt 424023 CANCER RES & DEVELP RESEARCH FOUNDATION OF CUNY CAB ACCT OFFICE-ROOM 209 155 ELIZABETH BLACKWELL ST SYRACUSE NY 13210 131988190 501(C)(3) 83064 CANCER RES & DEVELP SANFORD-BURNHAM MEDICAL RESEARCH INST 10901 NORTH TORREY PINES ROAD LA JOLLA CA 92037 510197108 501(C)(3) 311120 CANCER RES & DEVELP SCRIPPS RESEARCH INSTITUTE OFFICE OF SPONSORED PROGRAMS 10550 NTORREY PINES RD TPC-7 LA JOLLA CA 92037 033043594 501(C)(3) 971808 CANCER RES & DEVELP SOUTHERN RESEARCH INSTITUTE 2000 9TH AVENUE SOUTH BIRMINGHAM AL 352055305 630288868 501(C)(3) 112958 CANCER RES & DEVELP THE BROAD INSTITUTE INC 7 CAMBRIDGE CENTER CAMBRIDGE MA 02142 263428781 501(C)(3) 526942 CANCER RES & DEVELP THE HASTINGS CENTER INC 21 MALCOLM GORDON ROAD GARRISON NY 105244125 132662222 501(C)(3) 319172 CANCER RES & DEVELP THE SALK INSTITUTE SYMPOSIUM 356258 10010 N TORREY PINES ROAD LA JOLLA CA 920371099 952160097 501(C)(3) 22029 CANCER RES & DEVELP THE TOBIN TOUCH LLC 532 S DONALD AVE ARLINGTON HEIGHTS IL 60004 271035633 n/a 5220 CANCER RES & DEVELP TRUSTEES OF UNIVERSITY OF PENNSYLVANIA HOSPITAL OF THE UNIVERSITY OF PENNS 3400 SPRUCE STREET569 DULLES BUILD PHILADELPHIA PA 191044283 231352685 501(C)(3) 61461 CANCER RES & DEVELP TUFTS UNIVERSITY TUFTS UNIV SCHOOL OF MEDICINE 136 HARRISON AVE BOSTON MA 02111 042103634 501(C)(3) 59607 CANCER RES & DEVELP UNITED WAY OF GREATER PLYMOUTH 934 WEST CHESTNUT STREET BROCKTON MA 02301 042103940 501(C)(3) 25000 CANCER RES & DEVELP UNIVERSITY OF COLORADO FITZSIMMONS BLD 500MAIL STOP547 13001 EAST 17TH PLACESTE E6312PO AURORA CO 80045 454552631 501(C)(3) 152651 CANCER RES & DEVELP UNIVERSITY OF ILLINOIS ACCOUNTS RECEIVABLE - MC367 PO BOX 19448 SPRINGFIELD IL 627949448 362582852 501(C)(3) 31179 CANCER RES & DEVELP UNIVERSITY OF IOWA DEPARTMENT OF BIOLOGICAL SCIENCES 28 BBE IOWA CITY IA 522421324 237436761 501(C)(3) 66804 CANCER RES & DEVELP UNIVERSITY OF MASSACHUSETTS HARBOR CAMPUS BOSTON MA 021253393 046013152 501(C)(3) 26512 CANCER RES & DEVELP UNIVERSITY OF MICHIGAN 1015 LSA BUILDING RECEIVABLE ACCOUNT 990050 ANN ARBOR MI 481091382 352183753 501(C)(3) 13000 CANCER RES & DEVELP UNIVERSITY OF NEBRASKA-LINCOLN OFFICE OF RESEARCH MANAGEMENT 312 N 14TH STREET ALEXANDER WEST NE 685880431 470491233 501(C)(3) 103766 CANCER RES & DEVELP UNIVERSITY OF NEW MEXICO HEALTH SCIENCE CENTER MSC09 5520 1 UNIVERSITY OF NEW MEX ALBUQUERQUE NM 871310001 850275408 501(C)(3) 7555 CANCER RES & DEVELP UNIVERSITY OF NORTH CAROLINA CANCER CENTER UNC-CH CB7295 102 LINEBERGER COMPREHENSIVE CHAPEL HILL NC 275997295 591711424 501(C)(3) 80265 CANCER RES & DEVELP UNIVERSITY OF PITTSBURGH PO BOX 371220 PITTSBURGH PA 152517220 250965591 501(C)(3) 36215 CANCER RES & DEVELP UNIVERSITY OF SOUTHERN CALIFORNIA SPONSORED PROJECTS ACCOUNTING FILE NO 52095 LOS ANGELES CA 900742095 951642394 501(C)(3) 292285 CANCER RES & DEVELP UNIVERSITY OF TEXAS SW MEDICAL CENTER OFFICE OF POST AWARD ADMINSTRATION PO BOX 841765 DALLAS TX 752841765 752556007 501(C)(3) 134454 CANCER RES & DEVELP UNIVERSITY OF VIRGINIA DEPARTMENT OF NEUROSURGERY PO BOX 800906 CHARLOTTESVILLE VA 229080724 542009312 501(C)(3) 11076 CANCER RES & DEVELP UNIVERSITY OF WASHINGTON 550 SCHMITZ HALL PO BOX 355872 SEATTLE WA 981955872 943079432 501(C)(3) 83016 CANCER RES & DEVELP VANDERBILT UNIVERSITY MEDICAL CENTER DEPTOF CELL DEVELOPMENTAL BIOLOG 465 21ST AVENUE SOUTH 3144 MRBII NASHVILLE TN 372328240 620476822 501(C)(3) 31520 CANCER RES & DEVELP WASHINGTON UNIVERSITY CAMPUS BOX 1056 1 BROOKINGS DRIVE ST LOUIS MO 631304899 430653611 501(C)(3) 44161 CANCER RES & DEVELP WAYNE STATE UNIVERSITY ATTN PATERSON 4100 JOHN R-PRO1EP DETROIT MI 48201 383555142 501(C)(3) 23577 CANCER RES & DEVELP WEILL CORNELL MEDICAL COLLEGE 1300 YORK AVENUE DEPARTMENT OF PATHOLOGY ROOM-C302/ NEW YORK NY 10021 150532082 501(C)(3) 56108 CANCER RES & DEVELP WHITEHEAD INSTITUTE 9 CAMBRIDGE CENTER ROOM 317 ATTN DR BILL LUNDBERG CAMBRIDGE MA 02142 061043412 501(C)(3) 602587 CANCER RES & DEVELP YALE UNIVERSITY PATHOLOGY DEPARTMENT PO BOX 208023 NEW HAVEN CT 065208070 060646973 501(C)(3) 427425 CANCER RES & DEVELP 67 10 Schedule I, Line 2 Description of Organization's Procedures for Monitoring the Use of Grants Dana-Farber Cancer Institute, Inc. (DFCI) is responsible for the programmatic, administrative and financial monitoring of all awards made to sub-recipients under federal and non-federal sponsored projects. DFCI has the obligation, throughout the life of the award, to monitor the activities of sub-recipients to make certain that project objectives are completed and all funds are used for authorized purposes in compliance with applicable laws, regulations, and provisions of the prime contracts or grant agreements. Office of Research Accounting will monitor sub-recipients through OMB Circular A-133 reports. On a semi-annual basis, we will request certification of the OMB A-133 audit report from each sub-recipient. Circular A-133 requires that annual audits be completed within nine months of the end of the sub-recipients audit period. To this end certification letters must be prepared and distributed to every sub-recipient working on any externally sponsored award. The certification letters must be prepared and distributed annually, by June 30 of each year, requesting information about the sub-recipients' most recent completed fiscal year. The certification letters require the sub-recipient organization to state that the information they are providing fairly presents the standing of the organization in all material aspects and that they state one of the following [see Attachment A, page 1]: -They are subject to the requirements of A-133, the audit has been completed and there were no material conditions of non-compliance with federal regulations. -They are subject to the requirements of A-133, the audit has been completed, exceptions were noted and a copy of the audit report is provided. -They are subject to the requirements of A-133 but the audit has not been completed. -They are not subject to the requirements of A-133 because the organization did not receive $500,000 or more in federal awards during the fiscal year, is a for-profit corporation, or is a non-U.S. based entity. Follow up requests will be made to ensure that sub-recipients send reports: -Should no response to the certification letter be received within 60 days, a second certification letter will be sent. Should no response to the second letter be received within 30 days, the sub-recipient will be contacted by telephone. -If reports are not received, the Federal Audit Clearinghouse (FAC) Internet data dissemination system will be used to retrieve audit report information from the FAC database. This information will be reviewed to determine if an organization has any reportable conditions and/or audit findings required to be reported under OMB Circular A-133, subpart E, section .510(a). -Should attempts continue to be unsuccessful, the Director of Research Administration, in conjunction with Director of the Research Accounting will consider sanctions against the sub-recipient, including termination of the subcontract. Research Accounting will review all available information for compliance issues pertaining to funds from A-133 reports. The Director of Research Accounting will be notified of any compliance issues that pertain to funds passed through the Institute and will request corrective action plans from the management of the organization to determine if proper action has been implemented. Management will determine corrective action on deficiencies identified in audits and sub-recipient monitoring. The monitoring of sub-recipients, not subject to Circular A-133, will be based upon the judgment of management and will include such factors as the size of the award, percentage of the total program's funds awarded to the sub-recipient, budget adherence, any issues identified in the pre-award review, and other matters as deemed necessary. The complete Sub-Recipient Policy is available upon request. X X false true X X X X X false true false false false false false false false Bartel Sylvia 212460 0 15836 0 -5762 0 0 0 41587 0 264121 0 0 0 Benz Edward J JR MD 740117 130609 229321 0 98388 0 175868 0 45899 0 1289593 130609 0 0 Boskey Richard S ESQ 439227 0 57836 0 18468 0 0 0 50426 0 565957 0 0 0 Constantine Michael MD 554506 0 269943 0 36089 0 0 0 39857 0 900395 0 0 0 Griffin James D MD 526406 0 71389 0 477431 0 0 0 44462 0 1119688 0 299415 0 Herring Thomas 149990 0 0 0 -4533 0 0 0 15366 0 160823 0 0 0 Kaddis Mona MD 499055 0 176282 0 38552 0 0 0 28042 0 741931 0 0 0 Nadler Lee MD 523280 0 71355 0 35470 0 0 0 45475 0 675580 0 0 0 Nathan David G MD 223871 0 0 0 6134 0 0 0 29056 0 259061 0 0 0 Papola Maria 283824 0 19699 0 -917 0 0 0 35568 0 338174 0 0 0 Paresky Susan 488941 0 64385 0 25956 0 0 0 44281 0 623563 0 0 0 Porter Janet 136189 0 67125 0 10375 0 0 0 20139 0 233828 0 0 0 Puhy Dorothy 552350 0 117125 0 36733 0 0 0 36324 0 742532 0 0 0 Reid Ponte Patricia 337318 0 43176 0 7027 0 0 0 43049 0 430570 0 0 0 Rollins Barrett J MD PHD 499344 0 65755 0 30498 0 0 0 39091 0 634688 0 0 0 Sallan Stephen E MD 409464 0 53921 0 28258 0 0 0 39091 0 530734 0 0 0 Shulman Lawrence N MD 524344 0 76940 0 35972 0 0 0 0 0 637256 0 0 0 Bird Karen 352318 0 43176 0 4508 0 0 0 50664 0 450666 0 0 0 Bunnell Craig 359135 0 38300 0 12178 0 0 0 35406 0 445019 0 0 0 Gettleman Wendy 180202 0 0 0 -6126 0 0 0 30075 0 204151 0 0 0 Kantoff Philip 477817 0 68712 0 29039 0 0 0 48685 0 624253 0 0 0 Winer Eric 445416 0 16853 0 135947 0 0 0 48453 0 646669 0 0 0 PART I, LINES 1A Tax indemnification and gross-up payments The following individuals received tax gross-up payments during the year that were associated with DFCI's 457(f) plan and were treated as taxable compensation: Benz, Edward J. JR., MD Boskey, Richard S., ESQ Puhy, Dorothy Bird, Karen Bunnell, Craig A., MD Griffin, James D., MD Papola, Maria Paresky, Susan Reid Ponte, Particia, RN Rollins, Barrett, MD, PHD Sallan, Stephen E., MD Shulman, Lawrence N., MD Constantine, Michael, MD Kaddis, Mona, MD Nadler, Lee, MD Kantoff, Philip, MD Winer, Eric, MD Membership Dues DFCI paid membership dues on behalf of the Sr. VP of Development, at the Harvard Club in Boston, MA. The club membership is used for a variety of reasons as this position's responsibilities are those of fundraising. This membership provides use of space as well as important networking opportunities. DFCI also paid for a membership for a former President of DFCI (Trustee), for networking purposes. Both memberships were utilized for business purposes, and therefore neither was included in taxable income. PART I, LINE 1B In general, DFCI does not pay for membership dues for its Trustees, Officers, Employees, etc. However, under these 2 particular circumstances it was determined by the President that these were appropriate expenditures and in the best interest of DFCI. Schedule J, Part 1, Line 4b The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Benz, Edward J. JR., MD 52,955 Boskey, Richard S., ESQ 16,143 Puhy, Dorothy 25,794 Bird, Karen 8,729 Bunnell, Craig A., MD 9,310 Griffin, James D., MD 23,580 Papola, Maria 2,886 Paresky, Susan 20,384 Reid Ponte, Particia, RN 7,449 Rollins, Barrett, MD, PHD 21,272 Sallan, Stephen E., MD 13,604 Shulman, Lawrence N., MD 23,405 Constantine, Michael, MD 25,978 Kaddis, Mona, MD 21,247 Nadler, Lee, MD 23,313 Winer, Eric, MD 16,671 A Mass Health and Educational Facilities 042456011 57586CZ24 2008-05-22 296490068 See Part VI false false false B Massachusetts Development Finance Agency 043431814 2012-07-02 57500000 See Part VI false false false A 57500000 0 301784408 8131608 4119476 0 2015100 116494 0 90335422 197066309 0 2011 true false true true B 0 0 57500000 0 0 0 0 0 0 0 57500000 0 2012 true false true true A false false true true true true 0 false false false true B false false true true true true 0 false false false true A false false false true true true morgan stanley 39.8 false false true trinity funding 2.8 true false true B false false false true true true morgan stanley 39.8 false false false 0 false true A true B true Part I (Bond Issues): 0 A(a)Issuer name: Massachusetts Health and Educational Facilities Authority, succeeded by Massachusetts Development Finance Agency May 4, 2004; Series I issued on February 8, 2007 and to partially finance the construction of the Yawkey Center for Cancer Care. B(f)Description of purpose: The bond issue was used to refund part of Series L-2 bonds issued 5/22/2008. Part IV (Arbitrage): 0 A2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2013 B2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2013 A4(b) Name of provider: Morgan Stanley Capital Services, Inc. B4(b) Name of provider: Morgan Stanley Capital Services, Inc. A5(b) Name of provider: Trinity Funding Company, LLC Patricia Ponte Tuition Assistance X 117395 27495 false true true Stephen Sallan Tuition Assistance X 262081 108575 false true true Dorothy Puhy Tuition Assistance X 197953 4045 false true true Lee Nadler Tuition Assistance X 403153 61029 false true true Edward Benz Housing Loan X 600000 341666 false true true Eric Winer Tuition Assistance X 401067 335227 false true true Phillip Kantoff Tuition Assistance X 258669 218728 false true true Karen Bird Tuition Assistance X 49550 39997 false true true 1136762 Bain Capital See Part V See Part V New England Patriots See Part V See Part V Berkshire Partners See Part V See part V OncoPep See Part V See part V Acetylon See Part V See Part V Part IV None of the trustees listed below vote on transactions that may be perceived as a conflict. Bain Capital Dana-Farber, Inc. (DFI), an organization related to DFCI, holds interests, through an investment pool, in alternative investments managed by Bain Capital. During FY 13, DFI transferred approximately $1,575,000 into these investments. Joshua Bekenstein owns >5% of Bain Capital. Berkshire Partners Dana-Farber, Inc. (DFI), an organization related to DFCI, holds interests in alternative investments managed by Berkshire Partners. During FY 13, DFI transferred approximately $1,345,000 into these investments. Richard Lubin owns >5% of Berkshire Partners LLC. Bristol Myers Squibb Fran Heller is a Senior Vice President at Bristol Myers Squibb (BMS). During FY 13, BMS transferred to DFCI $817,500 under sponsored research agreements and $596,000 in connection with clinical trials. New England Patriots Robert Kraft is the owner of the New England Patriots. The Patriots' practice field is named for DFCI (at no cost to DFCI). Although the value of goods and services exchanged between DFCI and the New England Patriots is under the reporting threshold, DFCI reported the relationship in any event. OncoPep Marc Cohen is on the board of and owns stock in OncoPep. Dana-Farber licensed technology to OncoPep and received shares in Oncopep in exchange for the license. Eventually DFCI could receive royalty payments from OncoPep. Acetylon Marc Cohen is the Chairman of the Board of Acetylon Pharmaceuticals. Marc Cohen, Sean Dobson, Robert Kraft, and Rebecca Sanders own directly or indirectly interests in Acetylon Pharmaceuticals. DFCI licensed technology to Acetylon. DFCI has the right to receive stock in Acetylon. DFCI has not yet received any payments related to the license. In FY13, Acetylon did make payments for sponsored research to Dana Farber/Partners Cancer Care totaling $331,250. It is likely DFCI was allocated a portion for this amount for clinical trials conducted at DFCI. allocated a portion for this amount for clinical trials conducted at DFCI. X 1051774 Letter from Donor X 26 276252 Letter from Donor X Airline & Hotel Stay 3 27025 Letter from Donor X Advertising 12 3234489 Letter from Donor X Memorabilia/Sp Tix 3 7561 Letter from Donor X Miscellaneous 12 126541 Letter from Donor false true false Schedule M, Part I, Line 33 DFCI received donations of art, books, and other goods that it displays in its properties. These goods have values that are either nominal or are not readily determinable, and are therefore not included as revenue. Part VI, Question 2 Business & Family Relationships Family Relationship: David Perini, Eileen Perini, and Daughter Jennifer Perini Family Relationship: Richard Smith, Susan Smith, and Daughter Amy Berylson Business Relationship: Richard Lubin and Christopher Hadley (Bershire Partners) Business Relationship: Charles Dana III and Ed Rover (Dana Foundation) Part VI, Question 4 The Bylaws of DFCI were amended and adopted by the Board of Trustees twice since the last 990 was filed, once in January of 2013 and once in April of 2013. The Bylaws were amended for the following reasons: - To increase the number of maximum Governing (voting) Trustees from 75 to 85 - To institute two three year terms for the committee chairs - To eliminate the requirement for the Secretary of the Board to serve as the Chair of the Governance Committee. - To add the President as an ex officio member of the Investment Committee and Finance Committee and provide that the President counts for purposes of the quorum only if he attends. - To allow the President to nominate up to two executive leaders ex officio trustees if they serve positions similar to other ex officio trustees. Part VI, Question 11 Process used to review the Form 990 The Form 990 is prepared by the Tax Department and independently reviewed by Ernst & Young, LLP for technical tax issues. After the Tax Department and Ernst & Young, LLP finalizes the returns, The Chief Financial Officer of the Organization meets with the Tax Department to review the entire tax return in detail. If any changes need to be made, the Tax Department will make the changes in accordance with the CFO. After the CFO approves the return, certain sections are taken to Board Committees for a more detailed analysis. For example, the Board Compensation Committee reviews all information related to compensation in Part VII and Schedule J. Once the return has been through the committees who review certain sections, the tax return is presented to the Audit Committee for review and approval. After the audit committee approves the tax return, an electronic message is sent to all Board members with a secured link to the tax return. The Board has the opportunity to review the return and if any issues arise, they can bring them to the appropriate executive management individuals. A final version of the form is made available to the Board before filing with the IRS. The return is only filed after each of the steps in the review process is complete. Part VI, Question 12c Monitoring & Enforcement of Conflict of Interest Policy The Office of General Counsel, the Assistant Secretary of the Board, and the Tax Department drafts a Conflict of Interest Disclosure Questionnaire each year and has all trustees, officers, and key employees fill out a questionnaire in regards to their personal situation and personal and business relationships. The Assistant Secretary compiles the list of Disclosures and gathers financial data from the Accounts Payable and Payroll Department for all organizations, employees, independent contractors, and other miscellaneous transactions which were disclosed by all individuals. Once all of this information is compiled, the Office of General Counsel and the Tax Department goes through each transaction and disclosure to determine what needs to be disclosed on the tax return. The Tax Department and the Office of General Counsel also discusses if there are any other known transactions that have not been disclosed. If there are any questions regarding such situation, the Office of General Counsel and the Assistant Secretary will discuss the questions with the individual trustees involved. In addition the process described above, the governance committee of the board of directors annually reviews any new conflict of interest disclosures and they address any issues that may arise. The governance committee is also responsible to bring any major issues related to the conflict of interest policy to the executive committee and the entire Board if deemed necessary. Per DFCI's conflict of interest policy, in order to avoid a conflict of interest or an appearance of a conflict of interest: 1. A Trustee should not participate in a vote on a transaction in which the Trustee or family member has a financial interest and should disclose any potential conflict before DFCI acts on the transaction. 2. A Trustee, a member of his or her family, or an entity with which one or more of them has a material interest, may not do business with DFCI unless expressly authorized by DFCI after full disclosure. 3. A Trustee should fully disclose his or her association (including employment, consulting, or membership on a governing board by the Trustee or a family member) with an entity that competes with or has interests conflicting with those of DFCI and should refrain from participating in any vote of other the organization if the vote affects DFCI. Once a disclosure has been made, DFCI's Office of General Counsel reviews such conflict and may discuss the matter with the appropriate parties. The Office of General Counsel will then review the matter with the Chairman of the Board. Final decisions are made with the chairman and possibly the Board's Executive Committee. Part VI, Question 15a Process for determining compensation of President Per DFCI's Executive Compensation Philosophy, annually the Compensation Committee of the Board of Trustees reviews the President's (DFCI's Chief Executive Officer) performance and makes a recommendation regarding compensation to the Executive Committee. The Executive Committee acts on the recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Executive Committee is reported to the full Board. Annually, following the filing of Form 990s, DFCI compares the information it reports for its President to the compensation of Presidents/CEO's at other area healthcare organizations as well as other institutions that are considered designated comprehensive cancer centers. The Board completed this process as of June 25, 2013. Part VI, Question 15b Process for determining compensation of officers and key employees Per DFCI's Executive Compensation Philosophy, annually the DFCI President reviews the performance of Officers and Key Employees and makes a recommendation as to their compensation to the Compensation Committee of the Board of Trustees. The Compensation Committee establishes compensation for those individuals based on that recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Compensation Committee is reported to the Executive Committee of the Board of Trustees and to the full Board. Annually, following the filing of Form 990s DFCI compares the compensation of these individuals with those at other area healthcare organizations as well as other institutions that are considered designated cancer centers. Part VI, Question 19 Availability of Governing Documents, Conflict of Interest Policy, and Financial Statements to the Public Governing Documents - Governing Documents - We currently provide the governing documents upon request. The Governing Documents are also available to the Public on the Secretary of the Commonwealth's website. Conflict of Interest Policy - DFCI's Conflict of Interest Policy can be found within its Code of Conduct, which is available on its website. Financial Statements - The organization uses the services of Digital Assurance Certification LLC (DAC) to report annual audited financial statements and other relevant organizational information as required by certain regulatory and tax laws. DAC is a website (www.dacbond.com) free to the public that publishes tax-exempt bond issuers' financial and legal documents such as the Audited Financial Statements. Fiscal Year 2001 through the latest issue date of the Audited Financial Statements for Dana-Farber Cancer Institute, Inc. can be found on the DAC website. PART XI LINE 5 OTHER CHANGES IN NET ASSETS CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATE $86,769,000 CHANGE IN VALUE OF SWAP AGREEMENT $18,764,301 PENSION ADJUSTMENT $6,217,000 OTHER CHANGES IN NET ASSETS 1,351,669 Dana-Farber Inc 450 Brookline Avenue BP418 BOSTON MA 02215 043102433 INVEST MGMT MA 11A, TYPE 1 DFCI true DANA-FARBER TRUST INC 450 Brookline Avenue BP418 BOSTON MA 02215 300195757 DFCI RE MGMT MA 11A DFCI true DANA-FARBERPARTNERS CANCER CARE INC 450 Brookline Avenue BP418 BOSTON MA 02215 043320640 ONCOL SUP ORG MA 11c FI DFCI false RMSA TRUST 450 Brookline Avenue BP418 BOSTON MA 02215 562656539 RETRMT TRUST MA DFCI true Friends of Dana-Farber Cancer Institute 450 Brookline Ave BP418 Boston MA 02215 371613621 Fundraising MA 11A, TYPE 1 DFCI true Dana-FarberChildren's Hospital Cancer C 450 Brookline Ave BP418 Boston MA 02215 043554536 Pediatric Onc MA Type 1 N/A false Dana-Farber Master Tr for Retirement Pl 450 Brookline Ave BP418 Boston MA 02215 466487094 RETRMT Trust DFCI true DANA-FARBERPARTNERS CANCER CARE 450 Brookline Avenue BP418 BOSTON MA 02215 043402364 ONCOLOGY PTNR MA Related 44867872 false 0 0.50000 false true true false false false false false false false false false true true true false false true true Dana-Farber Partners Cancer Care Inc O 130609 CASH Dana-Farber Partners Cancer Care Inc R 353990 CASH Dana-Farber Partners Cancer Care Inc L 25300268 CASH Dana-Farber Inc R 39802376 CASH Dana-Farber Inc S 174929701 CASH Friends of Dana-Farber Cancer Institute Inc O 167909 Actual Expense RMSA Trust R 146771 CASH Friends of Dana-Farber Cancer Institute Inc B 50000 Cash Friends of Dana-Farber Cancer Institute Inc C 693466 Cash